Surmodics Shares Outstanding 2010-2025 | SRDX
Surmodics shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Surmodics Annual Shares Outstanding (Millions of Shares) |
2024 |
14 |
2023 |
14 |
2022 |
14 |
2021 |
14 |
2020 |
14 |
2019 |
14 |
2018 |
13 |
2017 |
13 |
2016 |
13 |
2015 |
13 |
2014 |
14 |
2013 |
15 |
2012 |
17 |
2011 |
17 |
2010 |
17 |
2009 |
17 |
Surmodics Quarterly Shares Outstanding (Millions of Shares) |
2025-03-31 |
14 |
2024-12-31 |
14 |
2024-09-30 |
14 |
2024-06-30 |
14 |
2024-03-31 |
14 |
2023-12-31 |
14 |
2023-09-30 |
14 |
2023-06-30 |
14 |
2023-03-31 |
14 |
2022-12-31 |
14 |
2022-09-30 |
14 |
2022-06-30 |
14 |
2022-03-31 |
14 |
2021-12-31 |
14 |
2021-09-30 |
14 |
2021-06-30 |
14 |
2021-03-31 |
14 |
2020-12-31 |
14 |
2020-09-30 |
14 |
2020-06-30 |
14 |
2020-03-31 |
14 |
2019-12-31 |
14 |
2019-09-30 |
14 |
2019-06-30 |
14 |
2019-03-31 |
14 |
2018-12-31 |
14 |
2018-09-30 |
13 |
2018-06-30 |
13 |
2018-03-31 |
13 |
2017-12-31 |
13 |
2017-09-30 |
13 |
2017-06-30 |
13 |
2017-03-31 |
13 |
2016-12-31 |
13 |
2016-09-30 |
13 |
2016-06-30 |
13 |
2016-03-31 |
13 |
2015-12-31 |
13 |
2015-09-30 |
13 |
2015-06-30 |
13 |
2015-03-31 |
13 |
2014-12-31 |
13 |
2014-09-30 |
14 |
2014-06-30 |
14 |
2014-03-31 |
14 |
2013-12-31 |
14 |
2013-09-30 |
15 |
2013-06-30 |
15 |
2013-03-31 |
15 |
2012-12-31 |
15 |
2012-09-30 |
17 |
2012-06-30 |
18 |
2012-03-31 |
18 |
2011-12-31 |
18 |
2011-09-30 |
17 |
2011-06-30 |
18 |
2011-03-31 |
17 |
2010-12-31 |
17 |
2010-09-30 |
17 |
2010-06-30 |
17 |
2010-03-31 |
17 |
2009-12-31 |
17 |
2009-09-30 |
17 |
2009-06-30 |
17 |
2009-03-31 |
17 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$0.398B |
$0.126B |
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
|